Reading size

PACK IN HAND · ONE-PAGE CHECK

Medicine pack check sheet

Print this sheet or fill it in before speaking with a pharmacist or clinician. Copy only what is printed on the pack in hand. The published fields below are starting points from this record, not proof that your pack is the same product.

Published record starting point

Record display name
CREON
Generic name / active ingredient
pancrelipase
Dosage-form class
Pancrelipase delayed-release oral capsule: each capsule is identified jointly by lipase, protease and amylase USP units. This dossier establishes only five exact bottle identities and does not infer an individual's capsule count, conversion or course from the numbers.
Route
Oral
Record reviewed
2026-08-23

Copy from the pack in hand

Source-linked reading points

  • First check CREON, pancrelipase, delayed-release capsule and lipase USP units per capsule. 3,000, 6,000, 12,000, 24,000 and 36,000 are not milligrams and are not a rule for self-exchanging, assembling or reducing different capsules; the label handles use together with individual factors and diet.
  • “Delayed release” means the capsule contains enteric-coated pellets. The label's handling text for this exact product includes swallowing whole and not crushing or chewing, with separate limited wording for swallowing difficulty. It is not permission to split, crush, chew, divide pellets for later use, store a mixture or replace with another pancreatic enzyme product.
  • The label explicitly cautions against treating another pancreatic enzyme product as a self-substitute for CREON. With different strengths, older packs, another enzyme product, supplements or multiple chronic medicines at home, have a pharmacist or prescribing team review every actual pack, prescription and complete medicine list; do not self-combine, alternate or convert from “all are enzymes,” colour or unit numbers.
  • With persistent or marked abdominal pain, bloating, vomiting, rash/breathing trouble, mouth pain or another acute serious concern, use local urgent or established care; do not wait for a webpage or self-stop, make up, alter capsule contents or change products because of a concern.

Reviewed presentation examples — compare every field

  • Per capsule: lipase 3,000 USP units; protease 9,500 USP units; amylase 15,000 USP units; 70-capsule bottleNDC 0032-1203-70
  • Per capsule: lipase 6,000 USP units; protease 19,000 USP units; amylase 30,000 USP units; 100-capsule bottleNDC 0032-1206-01
  • Per capsule: lipase 12,000 USP units; protease 38,000 USP units; amylase 60,000 USP units; 250-capsule bottleNDC 0032-1212-07
  • Per capsule: lipase 24,000 USP units; protease 76,000 USP units; amylase 120,000 USP units; 100-capsule bottleNDC 0032-1224-01
  • Per capsule: lipase 36,000 USP units; protease 114,000 USP units; amylase 180,000 USP units; 100-capsule bottleNDC 0032-3016-13

EDITORIAL RECORD

Who prepared and checked this page

Byline
OriginDrug Content Editorial
Review role
Public primary-source verification
Last reviewed
2026-08-23
Source record
1 clickable primary-source entry point is listed with this dossier.

The review role checks source traceability, stated market, document version and product-identity fields. It is not a claim of clinical licensure, prescribing authority or individual pharmacy service. Read the editorial policy.

Search records
Enlarged public-label image